CryoLife BioGlue Vascular Approval To Double Sales Of The Adhesive In 2002
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of CryoLife's BioGlue for vascular repair procedures, announced Dec. 4, is expected to roughly double sales of the surgical adhesive to $22-24 mil. in 2002, the firm says